Endocrine Abstracts

Subclinical atherosclerosis is frequently present in women with polycystic ovary syndrome (PCOS). Metformin and liraglutide both improve metabolic control in PCOS, however they might exert different anti-atherosclerotic effects. We investigated the impact of these medications on the subclinical atherosclerotic changes of the arterial wall in PCOS patients.Results: 25 patients on metformin and 40 patients on liraglutide completed the study. Metformin impr...